Physician profile
Sarah Lower
NPI 1134657323
$963.70
in general payments reported to CMS, 2019-2025
17 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2023: $439 · 2024: $237 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $140.04 | 2023-2024 | Azstarys |
| Janssen Pharmaceuticals, INC | $100.07 | 2023 | Xarelto |
| Alexion Pharmaceuticals, INC. | $99.60 | 2023 | |
| Medtronic, INC. | $97.89 | 2023-2025 | Corevalve Evolut R, Interstim |
| Alk-Abello, INC | $88.53 | 2024-2025 | Neffy, Grastek, Odactra |
| Depuy Synthes Sales INC. | $83.31 | 2024 | Na, Rapidsorb, Trumatch |
| Astrazeneca Pharmaceuticals LP | $73.98 | 2021 | |
| Supernus Pharmaceuticals, INC. | $65.03 | 2024 | Qelbree |
| Medicure Pharma INC. | $43.01 | 2021 | |
| Neos Therapeutics, LP | $29.73 | 2023-2024 | Cotempla Xr-Odt |
| Tris Pharma INC | $28.87 | 2023 | Dyanavel Xr |
| Noven Therapeutics, LLC | $21.98 | 2024 | Xelstrym, Secuado |
| Sanofi Pasteur INC. | $21.86 | 2023 | |
| Merck Sharp & Dohme LLC | $20.91 | 2023 | Gardasil 9, Vaxneuvance |
| Collegium Pharmaceutical, INC. | $17.66 | 2025 | Jornay Pm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $17.12 | 2025 | Doc Band |
| Pfizer INC. | $14.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Lower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.